Posted in Non classifié(e)

Réalisation d’une importante commande d’instruments de diagnostic moléculaire q16 Croissance dans le marché du diagnostic clinique dans un marché chinois en forte croissance

Novacyt q16 en Chine Paris, France et Camberley, UK – le 6 décembre 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce aujourd’hui qu’il a reçu une autre commande importante pour les instruments de diagnostic moléculaire q16 de Primerdesign d’un nouveau client sur le marché chinois en forte croissance. La

Visit Page
Posted in Board, Novacyt Group, NOVAPREP®, Products, Services, Uncategorized

Liquidity Agreement Monthly Update and Total Voting Rights

PParis, France and Camberley, UK – 3 December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised

Visit Page
Posted in Uncategorized

The following announcement replaces the announcement released on 30 May 2018 at 18:30 (UK time) under RNS number 7508P.

Replacement Announcement – Novacyt 30-11-18

Visit Page